Erasca (ERAS) Net Income (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Erasca | 4.21 Bn | 3.97 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -531.80% |
| Dec 31, 2025 | 5.03% |
| Sep 30, 2025 | 9.74% |
| Jun 30, 2025 | -9.40% |
| Mar 31, 2025 | -1.76% |
| Dec 31, 2024 | 3.01% |
| Sep 30, 2024 | 50.36% |
| Jun 30, 2024 | -80.49% |
| Mar 31, 2024 | -17.90% |
| Dec 31, 2023 | 2.17% |
| Sep 30, 2023 | 4.47% |
| Jun 30, 2023 | 4.27% |
| Mar 31, 2023 | 75.45% |
| Dec 31, 2022 | -281.10% |
| Sep 30, 2022 | 0.33% |
| Jun 30, 2022 | 2.33% |
| Mar 31, 2022 | -17.73% |
| Dec 31, 2021 | 32.78% |
| Sep 30, 2021 | -63.28% |
| Jun 30, 2021 | -43.71% |
| Mar 31, 2021 | 70.67% |
| Dec 31, 2020 | -499.54% |
| Sep 30, 2020 | -54.04% |